Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Hepregen Announces Issuance of its First Patent

Published: Tuesday, May 28, 2013
Last Updated: Monday, June 03, 2013
Bookmark and Share
The patent protects manufacturing methods of Hepatopac and related products.

Hepregen Corporation announced today the issuance of a U.S. patent by the United States Patent and Trademark Office (“USPTO”) that protects a key element of the method the Company uses to manufacture its HepatoPacTM and related products. All 20 inventive claims in the original patent application were issued. This patent, entitled Systems and Methods for Micro-Contact Stamping along with Hepregen’s foundational patents, which were licensed from the Massachusetts Institute of Technology (“MIT”), ensure product protection for years to come. 

Dr. Jack McGeehan, Hepregen’s Vice President of Operations and named inventor on the newly issued patent, said, “Hepregen is very pleased by the rapid and positive USPTO review of this patent application. The issued claims protect both the structure and method of use of a device absolutely essential to the reproducible manufacture of Hepregen’s unique product portfolio.” 

Dr. Vincent Zurawski, Hepregen’s Chief Executive Officer, also commented, stating, “This important patent, the first issued by Hepregen, adds another picket to a fence of issued patents and patent applications licensed from MIT, all protecting the Company’s simple, elegant, ‘liver-in-a-dish’ products.” Dr. Zurawski added, “Hepregen’s pharmaceutical industry customers continue to utilize these HepatoPacTM products to mitigate risk in the drug development process and reduce the cost of bringing candidate drugs to the clinic.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hepregen Corporation and The Hamner Institutes for Health Sciences Announce Research Partnership
Agreement provides opportunity to collaborate on research supporting next generation in vitro micro-liver analysis associated with pharmaceutical and chemical product development.
Tuesday, August 13, 2013
QPS Holdings and Hepregen Corporation Announce Commercial Partnership
The agreement provides co-promotion, marketing and sales of services utilizing Hepregen’s proprietary HepatoPac products.
Thursday, May 30, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos